{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:41:00Z","timestamp":1790091660179,"version":"4.0.1"},"reference-count":200,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bbcan.2024.189218","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T11:49:54Z","timestamp":1731671394000},"page":"189218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Epstein Barr virus: A cellular hijacker in cancer"],"prefix":"10.1016","volume":"1879","author":[{"given":"Moyed","family":"Alsaadawe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakeel A.","family":"Radman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohenned","family":"Alsaadawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2024.189218_bb0005","article-title":"Viral causes of lymphoma: the history of Epstein-Barr virus and human T-Lymphotropic virus 1","volume":"8","author":"Esau","year":"2017","journal-title":"Virol.: Res. Treat."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189218_bb0010","first-page":"609","article-title":"Epstein-Barr virus and Burkitt lymphoma","volume":"33","author":"Rowe","year":"2014","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189218_bb0015","first-page":"159","article-title":"Denis Burkitt and the African lymphoma","volume":"3","author":"Magrath","year":"2009","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.bbcan.2024.189218_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.812224","article-title":"Epstein-Barr virus in Burkitt lymphoma in Africa reveals a limited set of whole genome and LMP-1 sequence patterns: analysis of archival datasets and field samples from Uganda, Tanzania, and Kenya","volume":"12","author":"Liao","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2024.189218_bb0025","article-title":"Burkitt lymphomas evolve to escape dependencies on Epstein-Barr virus","volume":"10","author":"Hutcheson","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"Pt 1","key":"10.1016\/j.bbcan.2024.189218_bb0030","first-page":"3","article-title":"Why and how Epstein-Barr virus was discovered 50 years ago","volume":"390","author":"Epstein","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bbcan.2024.189218_bb0035","first-page":"627","article-title":"Anthony Epstein (1921\u20132024)","author":"Rickinson","year":"2024","journal-title":"nature"},{"issue":"6177","key":"10.1016\/j.bbcan.2024.189218_bb0040","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1126\/science.1252786","article-title":"Virology. Epstein-Barr virus turns 50","volume":"343","author":"Lieberman","year":"2014","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.bbcan.2024.189218_bb0045","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3389\/fmicb.2016.01602","article-title":"Epstein-Barr virus: diseases linked to infection and transformation","volume":"7","author":"Jha","year":"2016","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41541-022-00587-6","article-title":"Urgency and necessity of Epstein-Barr virus prophylactic vaccines","volume":"7","author":"Zhong","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.bbcan.2024.189218_bb0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fonc.2018.00211","article-title":"Epstein-Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: an update","volume":"8","author":"Smatti","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2024.189218_bb0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fonc.2018.00211","article-title":"Nasrallah GKJFio: Epstein\u2013Barr virus epidemiology, serology, and genetic variability of LMP-1 oncogene among healthy population: an update","volume":"8","author":"Smatti","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2024.189218_bb0065","series-title":"Alves CEdC, Pontes GSJFiI: Epstein-Barr Virus: The Mastermind of Immune Chaos","first-page":"1297994","volume":"15","author":"Silva","year":"2024"},{"key":"10.1016\/j.bbcan.2024.189218_bb0070","series-title":"Epstein-Barr Virus","author":"KHK","year":"2023"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0075","doi-asserted-by":"crossref","first-page":"9829","DOI":"10.1038\/s41598-019-45986-3","article-title":"A reliable Epstein-Barr virus classification based on phylogenomic and population analyses","volume":"9","author":"Zanella","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0080","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12985-023-02187-9","article-title":"Epstein-Barr virus infection: the micro and macro worlds","volume":"20","author":"Huang","year":"2023","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","article-title":"Estimating the global burden of Epstein-Barr virus-related cancers","volume":"148","author":"Wong","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189218_bb0090","series-title":"O: Mononucleosis Facts and Statistics: What You Need to Know","author":"Serenity Mirabito","year":"2022"},{"key":"10.1016\/j.bbcan.2024.189218_bb0095","series-title":"Kissing the Epstein-Barr virus Goodbye","author":"Khanna","year":"2024"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0100","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12985-023-02187-9","article-title":"Epstein-Barr virus infection: the micro and macro worlds","volume":"20","author":"Huang","year":"2023","journal-title":"Virol. J."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189218_bb0105","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1158\/1055-9965.688.13.5","article-title":"Prevention: Epstein-Barr virus and breast cancer: state of the evidence for viral carcinogenesis","volume":"13","author":"Glaser","year":"2004","journal-title":"Cancer. Epidemiol. Biomakers. Prev."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0110","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/JVI.02183-15","article-title":"The missing link in Epstein-Barr virus immune evasion: the BDLF3 gene induces ubiquitination and downregulation of major histocompatibility complex class I (MHC-I) and MHC-II","volume":"90","author":"Quinn","year":"2016","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.bbcan.2024.189218_bb0115","doi-asserted-by":"crossref","first-page":"12616","DOI":"10.1073\/pnas.94.23.12616","article-title":"Inhibition of ubiquitin\/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein\u2013Barr virus nuclear antigen 1","volume":"94","author":"Levitskaya","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"32","key":"10.1016\/j.bbcan.2024.189218_bb0120","doi-asserted-by":"crossref","first-page":"29987","DOI":"10.1074\/jbc.M303977200","article-title":"Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP\/USP7","volume":"278","author":"Holowaty","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189218_bb0125","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1073\/pnas.1019599108","article-title":"Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression","volume":"108","author":"Maruo","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"14","key":"10.1016\/j.bbcan.2024.189218_bb0130","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1073\/pnas.0801053105","article-title":"EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes","volume":"105","author":"Kashuba","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.bbcan.2024.189218_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004304","article-title":"EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation","volume":"10","author":"Banerjee","year":"2014","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189218_bb0140","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1128\/MCB.25.5.1749-1763.2005","article-title":"SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen","volume":"25","author":"Knight","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2024.189218_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006500","article-title":"An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation","volume":"13","author":"Pei","year":"2017","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.bbcan.2024.189218_bb0150","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/JVI.02408-08","article-title":"Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2","volume":"83","author":"Saha","year":"2009","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.bbcan.2024.189218_bb0155","first-page":"2523","article-title":"Immunochemical analysis of the interaction of p53 with MDM2;--fine mapping of the MDM2 binding site on p53 using synthetic peptides","volume":"9","author":"Picksley","year":"1994","journal-title":"Oncogene"},{"issue":"6630","key":"10.1016\/j.bbcan.2024.189218_bb0160","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"issue":"48","key":"10.1016\/j.bbcan.2024.189218_bb0165","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.1038\/sj.onc.1207120","article-title":"Epstein\u2013Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-\u03baB2 to p52 via an IKK\u03b3\/NEMO-independent signalling pathway","volume":"22","author":"Eliopoulos","year":"2003","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bbcan.2024.189218_bb0170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/mp.52.6.307","article-title":"The Epstein-Barr virus and its association with human cancers","volume":"52","author":"Baumforth","year":"1999","journal-title":"Mole. Pathol."},{"issue":"6","key":"10.1016\/j.bbcan.2024.189218_bb0175","article-title":"The Association of Epstein-Barr Virus with Cancer","volume":"14","author":"Patel","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.bbcan.2024.189218_bb0180","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fped.2018.00417","article-title":"Overview of EBV-associated T\/NK-cell lymphoproliferative diseases","volume":"6","author":"Kimura","year":"2018","journal-title":"Front. Pediatr."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189218_bb0185","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/CCO.0000000000000889","article-title":"EBV-associated NK and T-cell lymphoid neoplasms","volume":"34","author":"Kimura","year":"2022","journal-title":"Curr. Opin. Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189218_bb0190","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00394-22","article-title":"Epstein-Barr virus genome deletions in Epstein-Barr virus-positive T\/NK cell lymphoproliferative diseases","volume":"96","author":"Wongwiwat","year":"2022","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0195","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-9378-9-34","article-title":"The role of EBV in the pathogenesis of Burkitt\u2019s lymphoma: an Italian hospital based survey","volume":"9","author":"Pannone","year":"2014","journal-title":"Infectious Agents Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2024.189218_bb0200","first-page":"1397","article-title":"Epstein-Barr virus and Burkitt lymphoma","volume":"60","author":"Brady","year":"2007","journal-title":"J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189218_bb0205","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1634\/theoncologist.2008-0036","article-title":"EBV-associated lymphoproliferative disorders: classification and treatment","volume":"13","author":"Carbone","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.bbcan.2024.189218_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-9378-9-34","article-title":"The role of EBV in the pathogenesis of Burkitt\u2019s Lymphoma: an Italian hospital based survey","volume":"9","author":"Pannone","year":"2014","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.bbcan.2024.189218_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101674","article-title":"Lymphomas associated with Epstein-Barr virus infection in 2020: results from a large, unselected case series in France","volume":"54","author":"Donzel","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0220","doi-asserted-by":"crossref","first-page":"58","DOI":"10.17305\/bjbms.2007.3092","article-title":"Association of Hodgkin\u2019s lymphoma with Epstein Barr virus infection","volume":"7","author":"Cickusi\u0107","year":"2007","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.bbcan.2024.189218_bb0225","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-981-10-7230-7_17","article-title":"EBV-encoded latent genes","volume":"1045","author":"Kanda","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"44","key":"10.1016\/j.bbcan.2024.189218_bb0230","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.3748\/wjg.v28.i44.6249","article-title":"Development of Epstein-Barr virus-associated gastric cancer: infection, inflammation, and oncogenesis","volume":"28","author":"Iizasa","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.bbcan.2024.189218_bb0235","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein\u2013Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat. Rev. Cancer."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189218_bb0240","first-page":"149","article-title":"Reactivation of Epstein-Barr virus from latency","volume":"15","author":"Amon","year":"2005","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189218_bb0245","first-page":"803","article-title":"Epstein-Barr virus and cancer","volume":"10","author":"Thompson","year":"2004","journal-title":"Am. Cancer. Soc."},{"issue":"22","key":"10.1016\/j.bbcan.2024.189218_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214389","article-title":"Epstein-Barr virus (EBV) epithelial associated malignancies: exploring pathologies and current treatments","volume":"23","author":"Shechter","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0255","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbcan.2024.189218_bb0260","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ebiom.2018.12.041","article-title":"Epstein-Barr virus, malaria and endemic Burkitt lymphoma","volume":"39","author":"Velavan","year":"2019","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.bbcan.2024.189218_bb0265","article-title":"EBV in Hodgkin lymphoma","volume":"1","author":"Massini","year":"2009","journal-title":"Mediterranean J. Hematol. Infectious Dis."},{"issue":"7","key":"10.1016\/j.bbcan.2024.189218_bb0270","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.7150\/jca.37282","article-title":"Epstein Barr virus associated lymphomas and epithelia cancers in humans","volume":"11","author":"Ayee","year":"2020","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0275","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000557","article-title":"Epstein-Barr virus-positive Posttransplant lymphoproliferative disease after solid organ transplantation: pathogenesis, clinical manifestations, diagnosis, and management","volume":"2","author":"Nijland","year":"2016","journal-title":"Transplant. Direct"},{"issue":"7","key":"10.1016\/j.bbcan.2024.189218_bb0280","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.7150\/jca.37282","article-title":"Epstein Barr virus associated lymphomas and epithelia cancers in humans","volume":"11","author":"Ayee","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189218_bb0285","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ajt.12004","article-title":"Epstein\u2013Barr virus infection and posttransplant lymphoproliferative disorder","volume":"13","author":"Green","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"6","key":"10.1016\/j.bbcan.2024.189218_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061414","article-title":"EBV and the pathogenesis of NK\/T cell lymphoma","volume":"13","author":"Montes-Mojarro","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0295","first-page":"74","article-title":"Oncology: How we treat NK\/T-cell lymphomas","volume":"15","author":"Tse","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0300","first-page":"4","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","volume":"43","author":"Al-Hakeem","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2024.189218_bb0305","doi-asserted-by":"crossref","first-page":"1116143","DOI":"10.3389\/fmicb.2023.1116143","article-title":"The role of Epstein-Barr virus in nasopharyngeal carcinoma","volume":"14","author":"Su","year":"2023","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189218_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030643","article-title":"Increased prevalence of EBV infection in nasopharyngeal carcinoma patients: a six-year cross-sectional study","volume":"15","author":"Al-Anazi","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0315","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1038\/s41598-023-38396-z","article-title":"A promising predictive biomarker combined EBV NDA with PNI for nasopharyngeal carcinoma in nonendemic area of China","volume":"13","author":"He","year":"2023","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bbcan.2024.189218_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/biology11060799","article-title":"Epstein-Barr virus association with breast Cancer: evidence and perspectives","volume":"11","author":"Arias-Calvachi","year":"2022","journal-title":"Biology"},{"issue":"3","key":"10.1016\/j.bbcan.2024.189218_bb0325","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.21873\/invivo.12860","article-title":"Incidence of epstein-barr virus among women with breast cancer using monoclonal antibodies for latent membrane protein 1 (LMP1)","volume":"36","author":"Salih","year":"2022","journal-title":"In Vivo"},{"issue":"8","key":"10.1016\/j.bbcan.2024.189218_bb0330","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.7150\/jca.93631","volume":"15","author":"Hsu","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189218_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13027-021-00366-3","article-title":"Cancer: Catching viral breast cancer","volume":"16","author":"Lawson","year":"2021","journal-title":"Infect. Agent. Cancer"},{"key":"10.1016\/j.bbcan.2024.189218_bb0340","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ebiom.2016.05.025","article-title":"Epstein\u2013Barr virus infection of mammary epithelial cells promotes malignant transformation","volume":"9","author":"Hu","year":"2016","journal-title":"eBioMedicine"},{"key":"10.1016\/j.bbcan.2024.189218_bb0345","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s10120-020-01095-z","article-title":"Epstein\u2013Barr virus-associated gastric cancer: disease that requires special approach","volume":"23","author":"Ignatova","year":"2020","journal-title":"Gastric cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2024.189218_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10060167","article-title":"Clinical importance of Epstein\u2212Barr virus-associated gastric Cancer","volume":"10","author":"Nishikawa","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2024.189218_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.583463","article-title":"EBV-positive gastric Cancer: current knowledge and future perspectives","volume":"10","author":"Sun","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2024.189218_bb0360","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/v15030714","article-title":"Epstein-Barr virus history and pathogenesis","volume":"15","author":"Yu","year":"2023","journal-title":"Viruses"},{"issue":"20","key":"10.1016\/j.bbcan.2024.189218_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13205189","article-title":"Epstein-Barr virus-associated malignancies and immune escape: the role of the tumor microenvironment and tumor cell evasion strategies","volume":"13","author":"Bauer","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bbcan.2024.189218_bb0370","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41375-022-01804-w","article-title":"Molecular profiling of EBV associated diffuse large B-cell lymphoma","volume":"37","author":"Frontzek","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.bbcan.2024.189218_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.734293","article-title":"Epstein-Barr virus epithelial cancers-a comprehensive understanding to drive novel therapies","volume":"12","author":"Han","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189218_bb0380","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000434683","article-title":"Epstein-Barr virus-associated gastric carcinoma: use of host cell machineries and somatic gene mutations","volume":"82","author":"Abe","year":"2015","journal-title":"Pathobiology"},{"key":"10.1016\/j.bbcan.2024.189218_bb0385","series-title":"Seminars in Cancer Biology","first-page":"473","article-title":"The significance of LMP1 expression in nasopharyngeal carcinoma","volume":"2002","author":"Tsao","year":"2002"},{"issue":"12","key":"10.1016\/j.bbcan.2024.189218_bb0390","first-page":"581","article-title":"Epstein-Barr virus and nasopharyngeal carcinoma","volume":"33","author":"Young","year":"2014","journal-title":"Chin. J. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2024.189218_bb0395","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ijc.10372","article-title":"Promiscuous expression of Epstein-Barr virus genes in Burkitt\u2019s lymphoma from the central African country Malawi","volume":"99","author":"Sa","year":"2002","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2024.189218_bb0400","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.18632\/oncotarget.6649","article-title":"Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma","volume":"7","author":"Zheng","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.bbcan.2024.189218_bb0405","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/cas.12718","article-title":"Quantification of Epstein\u2013Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China","volume":"106","author":"Zheng","year":"2015","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189218_bb0410","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1073\/pnas.0911948107","article-title":"AP-1 homolog BZLF1 of Epstein\u2013Barr virus has two essential functions dependent on the epigenetic state of the viral genome","volume":"107","author":"Kalla","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0415","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.01512-10","article-title":"A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas","volume":"85","author":"Ma","year":"2011","journal-title":"J. Virol."},{"issue":"2\u20133","key":"10.1016\/j.bbcan.2024.189218_bb0420","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12026-014-8496-1","article-title":"The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease","volume":"58","author":"Hatton","year":"2014","journal-title":"Immunol. Res."},{"key":"10.1016\/j.bbcan.2024.189218_bb0425","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.coviro.2015.09.007","article-title":"Epstein-Barr virus latency: current and future perspectives","volume":"14","author":"Kempkes","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.bbcan.2024.189218_bb0430","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/biom11091380","article-title":"Stress-induced epstein-barr virus reactivation","volume":"11","author":"Sausen","year":"2021","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.bbcan.2024.189218_bb0435","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.7150\/ijbs.16564","article-title":"Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis","volume":"12","author":"Li","year":"2016","journal-title":"Int. J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.bbcan.2024.189218_bb0440","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317717718","article-title":"Radiation-induced Epstein-Barr virus reactivation in gastric cancer cells with latent EBV infection","volume":"39","author":"Nandakumar","year":"2017","journal-title":"Tumour Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189218_bb0445","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.imj.2023.04.005","article-title":"Reactivation of Epstein-Barr virus in SFTSV infected patients","volume":"2","author":"Fang","year":"2023","journal-title":"Infect. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0450","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13027-023-00534-7","article-title":"Epstein-Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992-2008","volume":"18","author":"Sabourin","year":"2023","journal-title":"Infect. Agents Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2024.189218_bb0455","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.bjc.6603609","article-title":"Sustained elevation of Epstein\u2013Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma","volume":"96","author":"Ji","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2024.189218_bb0460","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/ijc.24179","article-title":"Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells","volume":"124","author":"Fang","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2024.189218_bb0465","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/nar\/gkp1169","article-title":"Epstein\u2013Barr Virus DNase (BGLF5) induces genomic instability in human epithelial cells","volume":"38","author":"Wu","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189218_bb0470","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.cbi.2010.09.020","article-title":"N-methyl-N\u2032-nitro-N-nitrosoguanidine induces and cooperates with 12-O-tetradecanoylphorbol-1, 3-acetate\/sodium butyrate to enhance Epstein-Barr virus reactivation and genome instability in nasopharyngeal carcinoma cells","volume":"188","author":"Huang","year":"2010","journal-title":"Chem. Biol. Interact."},{"issue":"26","key":"10.1016\/j.bbcan.2024.189218_bb0475","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa011610","article-title":"Serologic markers of Epstein\u2013Barr virus infection and nasopharyngeal carcinoma in Taiwanese men","volume":"345","author":"Chien","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0480","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1749-6632.2001.tb03865.x","article-title":"Quantitative analysis of Epstein-Barr virus DNA in plasma and serum: applications to tumor detection and monitoring","volume":"945","author":"Lo","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189218_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019100","article-title":"Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up","volume":"6","author":"Cao","year":"2011","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.bbcan.2024.189218_bb0490","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.bjc.6603609","article-title":"Sustained elevation of Epstein\u2013Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma","volume":"96","author":"Ji","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2024.189218_bb0495","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.7150\/ijbs.16564","article-title":"Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis","volume":"12","author":"Li","year":"2016","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189218_bb0500","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2217\/fmb.12.147","article-title":"Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis","volume":"8","author":"Saha","year":"2013","journal-title":"Future Microbiol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0505","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/jvi.71.1.586-594.1997","article-title":"Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation","volume":"71","author":"Miller","year":"1997","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.bbcan.2024.189218_bb0510","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1038\/sj.onc.1201258","article-title":"Epstein\u2013Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-\u03baB pathway involving TNF receptor-associated factors","volume":"14","author":"Eliopoulos","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2024.189218_bb0515","series-title":"Seminars in Cancer Biology","first-page":"435","article-title":"LMP1 structure and signal transduction","volume":"2001","author":"Eliopoulos","year":"2001"},{"issue":"5","key":"10.1016\/j.bbcan.2024.189218_bb0520","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1099\/0022-1317-69-5-1051","article-title":"Epstein\u2014Barr virus gene expression in nasopharyngeal carcinoma","volume":"69","author":"Young","year":"1988","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0525","first-page":"3","article-title":"Latent and lytic Epstein-Barr virus replication strategies","volume":"15","author":"Tsurumi","year":"2005","journal-title":"Seminars Cancer Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189218_bb0530","first-page":"329","article-title":"Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma","volume":"42","author":"F\u00e5hraeus","year":"1988","journal-title":"Asian. Pac. J. Cancer. Prev."},{"key":"10.1016\/j.bbcan.2024.189218_bb0535","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-230X(06)97004-3","article-title":"Lytic cycle switches of oncogenic human gammaherpesviruses","volume":"97","author":"Miller","year":"2007","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189218_bb0540","series-title":"Viral Replication Cycle - From Pathogenesis and Immune Response to Diagnosis and Therapy, IntechOpen","article-title":"Perspective Chapter: Modulation of Latent to Lytic Cycle Infection Switch and Its Implication in EBV Mediated Tumorigenicity\u2019","author":"Zhang","year":"2023"},{"issue":"23","key":"10.1016\/j.bbcan.2024.189218_bb0545","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/jnci\/94.23.1733","article-title":"Regulation of Epstein-Barr virus lytic cycle activation in malignant and nonmalignant disease","volume":"94","author":"Miller","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189218_bb0550","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/JVI.01790-12","article-title":"Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication","volume":"87","author":"Wille","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2024.189218_bb0555","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fmicb.2012.00322","article-title":"Adult T-cell leukemia: a review of epidemiological evidence","volume":"3","author":"Iwanaga","year":"2012","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbcan.2024.189218_bb0560","series-title":"T-Cell Lymphoma, An Issue of Hematology\/Oncology Clinics of North America","volume":"31","author":"Jacobsen","year":"2017"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0565","doi-asserted-by":"crossref","first-page":"19973","DOI":"10.1038\/s41598-020-76344-3","article-title":"Epstein-Barr virus peptides derived from latent cycle proteins alter NKG2A+NK cell effector function","volume":"10","author":"Mbiribindi","year":"2020","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bbcan.2024.189218_bb0570","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16071312","article-title":"The role of natural killer cells in the tumor immune microenvironment of EBV-associated nasopharyngeal carcinoma","volume":"16","author":"Li","year":"2024","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.bbcan.2024.189218_bb0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009868","article-title":"NK cells eliminate Epstein-Barr virus bound to B cells through a specific antibody-mediated uptake","volume":"17","author":"Alari-Pahissa","year":"2021","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189218_bb0580","doi-asserted-by":"crossref","DOI":"10.3390\/v13020300","article-title":"The role of NK cells in EBV infection and EBV-associated NPC","volume":"13","author":"Png","year":"2021","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.bbcan.2024.189218_bb0585","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061914","article-title":"The role of NK cells in EBV infection and related diseases: current understanding and hints for novel therapies","volume":"15","author":"Desimio","year":"2023","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.bbcan.2024.189218_bb0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011304","article-title":"EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells","volume":"19","author":"Dong","year":"2023","journal-title":"Plos. Pathog."},{"issue":"6","key":"10.1016\/j.bbcan.2024.189218_bb0595","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/1348-0421.12154","article-title":"Immunology: Chloroquine interferes with dengue-2 virus replication in U937 cells","volume":"58","author":"Farias","year":"2014","journal-title":"Microbiol. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189218_bb0600","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/rmv.1816","article-title":"Host genetics of Epstein\u2013Barr virus infection, latency and disease","volume":"25","author":"Houldcroft","year":"2015","journal-title":"Rev. Med. Virol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0605","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.84","article-title":"Epstein-Barr virus latent genes","volume":"47","author":"Kang","year":"2015","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189218_bb0610","article-title":"Epstein-Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma","volume":"13","author":"Ross","year":"2023","journal-title":"Life (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0615","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/v5010226","article-title":"Potential cellular functions of Epstein-Barr nuclear antigen 1 (EBNA1) of Epstein-Barr virus","volume":"5","author":"Smith","year":"2013","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.bbcan.2024.189218_bb0620","doi-asserted-by":"crossref","DOI":"10.1172\/JCI58092","article-title":"EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors","volume":"122","author":"White","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2024.189218_bb0625","series-title":"Fields\u2019 Virology","volume":"1","author":"Fields","year":"2007"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0630","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bbcan.2024.189218_bb0635","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","article-title":"Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals","volume":"9","author":"Caldwell","year":"1998","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0640","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/JVI.01302-06","article-title":"Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity","volume":"81","author":"Rovedo","year":"2007","journal-title":"J. Virol."},{"issue":"6533","key":"10.1016\/j.bbcan.2024.189218_bb0645","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/375685a0","article-title":"Inhibition of antigen processing by the internal repeat region of the Epstein\u2013Barr virus nuclear antigen-1","volume":"375","author":"Levitskaya","year":"1995","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0650","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein-Barr virus","volume":"25","author":"Hislop","year":"2007","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bbcan.2024.189218_bb0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005718","article-title":"An Epstein-Barr virus-encoded protein complex requires an origin of lytic replication in cis to mediate late gene transcription","volume":"12","author":"Djavadian","year":"2016","journal-title":"Plos. Pathog."},{"issue":"7","key":"10.1016\/j.bbcan.2024.189218_bb0660","first-page":"1845","article-title":"Nuclear factor-\u03baB activation is involved in LMP1-mediated transformation and tumorigenesis of rat-1 fibroblasts","volume":"60","author":"He","year":"2000","journal-title":"Cancer. Res."},{"issue":"15","key":"10.1016\/j.bbcan.2024.189218_bb0665","doi-asserted-by":"crossref","first-page":"10084","DOI":"10.1073\/pnas.152059399","article-title":"The Epstein\u2013Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases","volume":"99","author":"Tsai","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"28","key":"10.1016\/j.bbcan.2024.189218_bb0670","doi-asserted-by":"crossref","first-page":"14144","DOI":"10.1073\/pnas.1821752116","article-title":"EBV infection is associated with histone bivalent switch modifications in squamous epithelial cells","volume":"116","author":"Leong","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2024.189218_bb0675","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.629780","article-title":"The impact of Epstein-Barr virus infection on epigenetic regulation of host cell gene expression in epithelial and lymphocytic malignancies","volume":"11","author":"Leong","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2024.189218_bb0680","series-title":"Persistence and Latent Infection in vivo","first-page":"309","author":"EJE-BV","year":"2005"},{"issue":"5638","key":"10.1016\/j.bbcan.2024.189218_bb0685","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1126\/science.1088902","article-title":"Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1","volume":"301","author":"Yin","year":"2003","journal-title":"Science (New York, N.Y.)"},{"issue":"4","key":"10.1016\/j.bbcan.2024.189218_bb0690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004743","article-title":"Viral inhibition of the transporter associated with antigen processing (TAP): a striking example of functional convergent evolution","volume":"11","author":"Verweij","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbcan.2024.189218_bb0695","first-page":"119","article-title":"The Latent Membrane Protein 1 (LMP1)","volume":"391","author":"Kieser","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bbcan.2024.189218_bb0700","doi-asserted-by":"crossref","first-page":"1289313","DOI":"10.3389\/fimmu.2023.1289313","article-title":"Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival","volume":"14","author":"Sausen","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189218_bb0705","doi-asserted-by":"crossref","DOI":"10.3390\/v14051017","article-title":"Immunosuppressive tumor microenvironment and immunotherapy of Epstein-Barr virus-associated malignancies","volume":"14","author":"Zheng","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.bbcan.2024.189218_bb0710","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-Barr virus and systemic autoimmune diseases","volume":"11","author":"Houen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2024.189218_bb0715","series-title":"Epstein-Barr Virus and its Replication","first-page":"2348","author":"EJFsv","year":"1996"},{"issue":"5942","key":"10.1016\/j.bbcan.2024.189218_bb0720","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/306480a0","article-title":"Replication of Epstein\u2013Barr virus in human epithelial cells infected in vitro","volume":"306","author":"Sixbey","year":"1983","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0725","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189218_bb0730","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005286","article-title":"The incubation period of primary Epstein-Barr virus infection: viral dynamics and immunologic events","volume":"11","author":"Dunmire","year":"2015","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189218_bb0735","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(87)90216-9","article-title":"Epstein-Barr virus gp350\/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis","volume":"50","author":"Tanner","year":"1987","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2024.189218_bb0740","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1128\/JVI.74.6.2612-2619.2000","article-title":"Infection of primary human monocytes by Epstein-Barr virus","volume":"74","author":"Savard","year":"2000","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189218_bb0745","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3390\/molecules24050997","article-title":"Novel therapeutics for Epstein-Barr virus","volume":"24","author":"Andrei","year":"2019","journal-title":"Molecule"},{"key":"10.1016\/j.bbcan.2024.189218_bb0750","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1128\/mBio.01844-15","article-title":"Gammaherpesvirus infection of human neuronal cells","volume":"6","author":"Jha","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.bbcan.2024.189218_bb0755","series-title":"Epstein-Barr Virus Entry","first-page":"7825","volume":"81(15)","author":"LMJJov","year":"2007"},{"issue":"6367","key":"10.1016\/j.bbcan.2024.189218_bb0760","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/356347a0","article-title":"Epstein\u2013Barr virus infection and replication in a human epithelial cell system","volume":"356","author":"Li","year":"1992","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbcan.2024.189218_bb0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004656","article-title":"To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis","volume":"11","author":"Price","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bbcan.2024.189218_bb0770","doi-asserted-by":"crossref","first-page":"1001145","DOI":"10.3389\/fimmu.2022.1001145","article-title":"Epstein-Barr virus perpetuates B cell germinal center dynamics and generation of autoimmune-associated phenotypes in vitro","volume":"13","author":"SoRelle","year":"2022","journal-title":"Front. Immunol."},{"issue":"Pt 9","key":"10.1016\/j.bbcan.2024.189218_bb0775","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1099\/vir.0.066712-0","article-title":"Epstein-Barr virus, the germinal Centre and the development of Hodgkin\u2019s lymphoma","volume":"95","author":"Mohamed","year":"2014","journal-title":"J. Gen. Virol."},{"issue":"21","key":"10.1016\/j.bbcan.2024.189218_bb0780","doi-asserted-by":"crossref","first-page":"9964","DOI":"10.1128\/JVI.74.21.9964-9971.2000","article-title":"Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils","volume":"74","author":"Joseph","year":"2000","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189218_bb0785","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010254","article-title":"Epstein\u2013Barr virus oncoprotein\u2013driven B cell metabolism remodeling","volume":"18","author":"Burton","year":"2022","journal-title":"PLoS Pathog"},{"issue":"12","key":"10.1016\/j.bbcan.2024.189218_bb0790","doi-asserted-by":"crossref","DOI":"10.3390\/v13122344","article-title":"Molecular basis of Epstein-Barr virus latency establishment and lytic reactivation","volume":"13","author":"Murata","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.bbcan.2024.189218_bb0795","first-page":"1342455","article-title":"Targeting latent viral infection in EBV-associated lymphomas","volume":"15","author":"Kong","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0800","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1038\/s41467-024-48031-8","article-title":"Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers","volume":"15","author":"Wu","year":"2024","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.bbcan.2024.189218_bb0805","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235861","article-title":"New viral facets in Oral diseases: the EBV paradox","volume":"20","author":"Tonoyan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bbcan.2024.189218_bb0810","first-page":"1279","article-title":"Epstein-Barr virus infectious mononucleosis","volume":"70","author":"MHJAfp","year":"2004","journal-title":"Harvard Med. School"},{"issue":"4","key":"10.1016\/j.bbcan.2024.189218_bb0815","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/odi.12656","article-title":"Epstein\u2013Barr virus in the pathogenesis of oral cancers","volume":"24","author":"Guidry","year":"2018","journal-title":"Oral. Dis."},{"issue":"19","key":"10.1016\/j.bbcan.2024.189218_bb0820","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJM198405103101905","article-title":"Epstein\u2013Barr virus replication in oropharyngeal epithelial cells","volume":"310","author":"Sixbey","year":"1984","journal-title":"N Engl. J. Med."},{"issue":"8590","key":"10.1016\/j.bbcan.2024.189218_bb0825","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0140-6736(88)91604-2","article-title":"Role of epithelium in EBV persistence and pathogenesis of B-cell tumours","volume":"331","author":"Allday","year":"1988","journal-title":"Lancet"},{"issue":"Pt 1","key":"10.1016\/j.bbcan.2024.189218_bb0830","first-page":"151","article-title":"EBV Persistence--Introducing the Virus","volume":"390","author":"Thorley-Lawson","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"10","key":"10.1016\/j.bbcan.2024.189218_bb0835","article-title":"The cycle of EBV infection explains persistence, the sizes of the infected cell populations and which come under CTL regulation","volume":"9","author":"Hawkins","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189218_bb0840","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1084\/jem.190.4.567","article-title":"Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients","volume":"190","author":"Babcock","year":"1999","journal-title":"J. Exp. Med."},{"issue":"13","key":"10.1016\/j.bbcan.2024.189218_bb0845","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137265","article-title":"Virus-mediated inhibition of apoptosis in the context of EBV-associated diseases: molecular mechanisms and therapeutic perspectives","volume":"23","author":"Wy\u017cewski","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.bbcan.2024.189218_bb0850","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215451","article-title":"New look of EBV LMP1 signaling landscape","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2024.189218_bb0855","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.640207","article-title":"The role of EBV-encoded LMP1 in the NPC tumor microenvironment: from function to therapy","volume":"11","author":"Lo","year":"2021","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189218_bb0860","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41389-017-0005-7","article-title":"Cadherin 6 is activated by Epstein\u2013Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma","volume":"6","author":"Zuo","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bbcan.2024.189218_bb0865","first-page":"4","article-title":"Metastasis of nasopharyngeal carcinoma: What we know and do not know","volume":"2","author":"Guo","year":"2021","journal-title":"StatPearls"},{"key":"10.1016\/j.bbcan.2024.189218_bb0870","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.681377","article-title":"Transcription factors: the fulcrum between cell development and carcinogenesis","volume":"11","author":"Islam","year":"2021","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.bbcan.2024.189218_bb0875","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082296","article-title":"Transcription factors in Cancer development and therapy","volume":"12","author":"Vishnoi","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0880","first-page":"28","article-title":"Therapy t: Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.bbcan.2024.189218_bb0885","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1038\/s41388-019-0749-y","article-title":"mTORC2-mediated PDHE1\u03b1 nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma","volume":"38","author":"Zhang","year":"2019","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.bbcan.2024.189218_bb0890","article-title":"Nasopharyngeal carcinoma: the role of the EGFR in epstein-barr virus infection","volume":"10","author":"Peng","year":"2021","journal-title":"Pathogens (Basel, Switzerland)"},{"issue":"8","key":"10.1016\/j.bbcan.2024.189218_bb0895","first-page":"1839","article-title":"Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF\u03b1 prior to neoplasia","volume":"28","author":"Charalambous","year":"2007","journal-title":"Mol. Cell. Biol."},{"issue":"21","key":"10.1016\/j.bbcan.2024.189218_bb0900","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.3390\/cancers13215451","article-title":"New look of EBV LMP1 signaling landscape","volume":"13","author":"Wang","year":"2021","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2024.189218_bb0905","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030166","article-title":"EBV latent membrane protein 1 activates Akt, NF\u03baB, and Stat3 in B cell lymphomas","volume":"3","author":"Shair","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbcan.2024.189218_bb0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-9966-32-90","article-title":"Research CC: Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells","volume":"32","author":"Xu","year":"2013","journal-title":"J. Exp. Clin. Cancer. Res."},{"key":"10.1016\/j.bbcan.2024.189218_bb0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-4-551","article-title":"Epstein-Barr virus latent membrane protein LMP1 reduces p53 protein levels independent of the PI3K-Akt pathway","volume":"4","author":"Husaini","year":"2011","journal-title":"BMC Res. Notes"},{"issue":"9","key":"10.1016\/j.bbcan.2024.189218_bb0920","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1128\/jvi.68.9.5602-5612.1994","article-title":"Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers","volume":"68","author":"Rowe","year":"1994","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.bbcan.2024.189218_bb0925","first-page":"203","article-title":"How the Bcl-2 family of proteins interact to regulate apoptosis","volume":"16","author":"Van Delft","year":"2006","journal-title":"Genes Cells"},{"issue":"5","key":"10.1016\/j.bbcan.2024.189218_bb0930","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1158\/1535-7163.MCT-15-0730","article-title":"Expression profile of BCL-2, BCL-XL, and MCL-1 predicts pharmacological response to the BCL-2 selective antagonist venetoclax in multiple myeloma models","volume":"15","author":"Punnoose","year":"2016","journal-title":"Mol. Cancer. Ther."},{"issue":"4","key":"10.1016\/j.bbcan.2024.189218_bb0935","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1073\/pnas.0307808100","article-title":"Direct interactions between Epstein\u2013Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation","volume":"101","author":"Peng","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189218_bb0940","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1007\/s00253-022-12029-3","article-title":"The roles of DNA methylation on the promotor of the Epstein-Barr virus (EBV) gene and the genome in patients with EBV-associated diseases","volume":"106","author":"Zhang","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbcan.2024.189218_bb0945","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3389\/fimmu.2020.00367","article-title":"Role of viral and host microRNAs in immune regulation of Epstein-Barr virus-associated diseases","volume":"11","author":"Iizasa","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0950","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/317653","article-title":"Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection","volume":"183","author":"Ohga","year":"2001","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.bbcan.2024.189218_bb0955","doi-asserted-by":"crossref","DOI":"10.3390\/v14122700","article-title":"EBV association with lymphomas and carcinomas in the Oral compartment","volume":"14","author":"Ward","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.bbcan.2024.189218_bb0960","first-page":"156","article-title":"Epstein-barr virus sequence variation-biology and disease","volume":"1","author":"Tzellos","year":"2012","journal-title":"Pathogens (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0965","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1038\/s41598-021-84070-7","article-title":"The influence of human genetic variation on Epstein-Barr virus sequence diversity","volume":"11","author":"R\u00fceger","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0970","doi-asserted-by":"crossref","DOI":"10.3390\/biom12010017","article-title":"Do Epstein-Barr virus mutations and natural genome sequence variations contribute to disease?","volume":"12","author":"Farrell","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbcan.2024.189218_bb0975","article-title":"A comprehensive analysis of genetic diversity of EBV reveals potential high-risk subtypes associated with nasopharyngeal carcinoma in China","volume":"7(1):veab010","author":"Xue","year":"2021","journal-title":"Virus Evol."},{"issue":"5","key":"10.1016\/j.bbcan.2024.189218_bb0980","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24050997","article-title":"Novel therapeutics for Epstein-Barr Virus","volume":"24","author":"Andrei","year":"2019","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.bbcan.2024.189218_bb0985","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2024.189218_bb0990","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.2147\/IDR.S375624","article-title":"Treatment options for Epstein-Barr virus-related disorders of the central nervous system","volume":"16","author":"Andersen","year":"2023","journal-title":"Infect. Drug Resistance"},{"issue":"9","key":"10.1016\/j.bbcan.2024.189218_bb0995","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092565","article-title":"Targeted therapies for Epstein-Barr virus-associated lymphomas","volume":"12","author":"Pei","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2024.189218_bb1000","doi-asserted-by":"crossref","first-page":"1059133","DOI":"10.3389\/fimmu.2022.1059133","article-title":"EBV-associated diseases: current therapeutics and emerging technologies","volume":"13","author":"Chakravorty","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24001495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24001495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T04:00:15Z","timestamp":1733889615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X24001495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":200,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0304419X24001495"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189218","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein Barr virus: A cellular hijacker in cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189218"}}